Menu Home

Áåñïëàòíàÿ òåõíè÷åñêàÿ áèáëèîòåêà äëÿ ëþáèòåëåé è ïðîôåññèîíàëîâ Áåñïëàòíàÿ òåõíè÷åñêàÿ áèáëèîòåêà


Àíãëèéñêèé ÿçûê äëÿ ìåäèêîâ. Advances in blood component separation and plasma treatment for therapeutics (ñàìîå âàæíîå)

Êîíñïåêòû ëåêöèé, øïàðãàëêè

Ñïðàâî÷íèê / Êîíñïåêòû ëåêöèé, øïàðãàëêè

Êîììåíòàðèè ê ñòàòüå Êîììåíòàðèè ê ñòàòüå

Îãëàâëåíèå (ðàçâåðíóòü)

55. Advances in blood component separation and plasma treatment for therapeutics

The separation of blood cells from plasma is done routinely by centrifugal techniques.

Membranes for plasma separation.

Membrane modules vary in surface area from about 0,15 to 0,8 m 2. Membrane plasma separation is a relatively simple process. At relatively low transmembrane pressure (generally less than 50 mm Hg), adequate plasma fluxes can be achieved. Equipment requirements are only minimal and the operation is much akin to that for other extracorporeal treatment technologies as hemodialysis, hemofiltration and hemoperfusion.

Membrane of on-line plasma treatment.

Plasma exchange whether by centrifugal or membrane techniques requires that the plasma discarded be replaced by physiological solution, which in most cases is en albumin solution. Because essential plasma components as well as pathological ones, are removed during plasma exchange, techniques designed to remove only the pathological components would be highly desirable. Review of the disease states treated by plasma exchange reveals that mane of the marker solutes ere of f molecular weight larger (generally greater than 100 000 daltons) than albumin, suggesting membrane filtration as physical separation techniques for their removal.

With presently available membranes, selective passage of albumin (near 70 000 daltons) and lower molecular weight solutes with complete retention of larger molecular weight solutes is difficult to achieve. However, such a complete separation may not be desirable since many higher molecular weight solutes are normal components of plasma To apply some selectivity in the separation of the marker solutes with a high return to the normal constituents of plasma and thus no requirement for plasma product infusion, the technique of cryofiltration was applied.

Cryofiltration is the on-line technique of plasma treatment consisting of plasma cooling followed by membrane filtration. By cooling the plasma, cryogel is deposited on the membrane during the Filtration process. The cryogel has been shown to contain concentrated quantities of the marker solutes. Response to therapy in the majority of patients with rheumatoid arthritis has been from good to excellent. In treatments, decreases in marker solutes have been noted coupled with improvement in clinical sympto-mology.

Membrane technology appears very promising in the separation and treatment of plasma on-line. Chronic treatment therapies appear safe and well tolerated by the patients.

New words

centrifugal technique - öåíòðèôóæíûå òåõíîëîãèè

plasma exchange - ïëàçìîîáìåí

therapeutic - òåðàïåâòè÷åñêèé

metabolic - ìåòàáîëè÷åñêèé

multiple - ìíîæåñòâåííûé

extracorporeal - ýêñòðàêîðïîðàëüíûé

Àâòîð: Åëåíà Áåëèêîâà

<< Íàçàä: Atherosclerotic mechanisms

>> Âïåðåä: Artificial oxygen carries

Ðåêîìåíäóåì èíòåðåñíûå ñòàòüè ðàçäåëà Êîíñïåêòû ëåêöèé, øïàðãàëêè:

Ìóíèöèïàëüíîå ïðàâî. Øïàðãàëêà

Ñòðàõîâàíèå. Øïàðãàëêà

Èñòîðèÿ ìèðîâîé è îòå÷åñòâåííîé êóëüòóðû. Øïàðãàëêà

Ñìîòðèòå äðóãèå ñòàòüè ðàçäåëà Êîíñïåêòû ëåêöèé, øïàðãàëêè.

×èòàéòå è ïèøèòå ïîëåçíûå êîììåíòàðèè ê ýòîé ñòàòüå.

<< Íàçàä

Ïîñëåäíèå íîâîñòè íàóêè è òåõíèêè, íîâèíêè ýëåêòðîíèêè:

Àòîìíûé ñåêðåò âå÷íîãî áëåñêà çîëîòà 20.06.2026

Çîëîòî èçäàâíà ñ÷èòàåòñÿ ñèìâîëîì âå÷íîñòè è áëàãîðîäñòâà íå òîëüêî èç-çà ñâîåé ðåäêîñòè, íî è áëàãîäàðÿ óäèâèòåëüíîé õèìè÷åñêîé ñòîéêîñòè.  îòëè÷èå îò áîëüøèíñòâà ìåòàëëîâ, îíî íå îêèñëÿåòñÿ íà âîçäóõå, íå òóñêíååò è íå ïîêðûâàåòñÿ ðæàâ÷èíîé äàæå ñïóñòÿ òûñÿ÷åëåòèÿ. Ýòà óíèêàëüíàÿ èíåðòíîñòü ïîçâîëèëà çîëîòûì àðòåôàêòàì ñîõðàíÿòü ïåðâîçäàííûé áëåñê ñ äðåâíèõ âðåìåí. Îäíàêî òî÷íûé ìåõàíèçì òàêîé çàùèòû äîëãî îñòàâàëñÿ çàãàäêîé äëÿ ó÷åíûõ. Íåäàâíåå èññëåäîâàíèå àìåðèêàíñêèõ õèìèêîâ-âû÷èñëèòåëåé ðàñêðûëî, ÷òî äåëî íå ïðîñòî â ñëàáîì âçàèìîäåéñòâèè ñ êèñëîðîäîì, à â îñîáîé àòîìíîé ñòðóêòóðå ïîâåðõíîñòè ìåòàëëà. Ñîòðóäíèêè Òóëåéíñêîãî óíèâåðñèòåòà Ñàíòó Áèñâàñ è Ìýòüþ Ì. Ìîíòåìîð ïðîâåëè äåòàëüíîå êîìïüþòåðíîå ìîäåëèðîâàíèå, ÷òîáû ïîíÿòü, êàê ìîëåêóëû êèñëîðîäà âçàèìîäåéñòâóþò ñ ïîâåðõíîñòüþ çîëîòà. Ó÷åíûå ñðàâíèëè äâà îñíîâíûõ òèïà àòîìíûõ ñòðóêòóð: "ðåêîíñòðóèðîâàííûå" è "íåðåêîíñòðóèðîâàííûå" ïîâåðõíîñòè. Áûëî äîêàçàíî, ÷òî ïðèðîäíàÿ ñïîñîáíîñòü çîëîòà ê ïåðåñòðîéêå àòîìîâ èãðàåò êë ...>>

Ñìàðôîí Realme 16T 5G 20.06.2026

 ñåãìåíòå äîñòóïíûõ ñìàðòôîíîâ ñ àêöåíòîì íà äëèòåëüíóþ ðàáîòó áåç ïîäçàðÿäêè êîìïàíèÿ Realme ïðåäñòàâèëà èíòåðåñíóþ íîâèíêó - ìîäåëü Realme 16T 5G. Ãëàâíûì ïðåèìóùåñòâîì óñòðîéñòâà ñòàëà ïî-íàñòîÿùåìó âïå÷àòëÿþùàÿ áàòàðåÿ åìêîñòüþ 8000 ìÀ÷, êîòîðàÿ ñïîñîáíà îáåñïå÷èòü äî òðåõ äíåé àâòîíîìíîé ðàáîòû ïðè óìåðåííîì èñïîëüçîâàíèè. Ïðè ýòîì èíæåíåðàì óäàëîñü ñîõðàíèòü îòíîñèòåëüíî êîìïàêòíûé êîðïóñ òîëùèíîé ìåíåå 9 ìì è âåñ âñåãî 224 ãðàììà, ÷òî äåëàåò ñìàðòôîí óäîáíûì äëÿ ïîâñåäíåâíîãî íîøåíèÿ íåñìîòðÿ íà âíóøèòåëüíûé àêêóìóëÿòîð. Ñìàðòôîí îñíàùåí áîëüøèì 6,8-äþéìîâûì LCD-äèñïëååì ñ âûñîêîé ÷àñòîòîé îáíîâëåíèÿ 144 Ãö è ïèêîâîé ÿðêîñòüþ äî 1200 íèò. Òàêîå ñî÷åòàíèå îáåñïå÷èâàåò ïëàâíóþ êàðòèíêó â äèíàìè÷íûõ ñöåíàõ è êîìôîðòíîå âîñïðèÿòèå êîíòåíòà äàæå ïîä ïðÿìûìè ñîëíå÷íûìè ëó÷àìè. Çà ïðîèçâîäèòåëüíîñòü îòâå÷àåò ýíåðãîýôôåêòèâíûé ïðîöåññîð MediaTek Dimensity 6300, äîïîëíåííûé îïåðàòèâíîé ïàìÿòüþ LPDDR4X è íàêîïèòåëåì UFS 2.2. Äëÿ ýôôåêòèâíîãî îòâîäà òåïëà âî âðåìÿ ïðîäîëæèòåëüíûõ íàãðó ...>>

Ïðîáëåìà íàáîðà âåñà ïîñëå 40 19.06.2026

Ñ âîçðàñòîì ìíîãèå ëþäè çàìå÷àþò, ÷òî ïîääåðæèâàòü ïðèâû÷íûé âåñ ñòàíîâèòñÿ âñå ñëîæíåå, äàæå åñëè ðàöèîí è óðîâåíü àêòèâíîñòè ñóùåñòâåííî íå ìåíÿþòñÿ. Ó÷åíûå èç Êàðîëèíñêîãî èíñòèòóòà â Øâåöèè ðàñêðûëè îäíó èç êëþ÷åâûõ áèîëîãè÷åñêèõ ïðè÷èí ýòîãî ÿâëåíèÿ. Îíè ïîêàçàëè, ÷òî ñ ãîäàìè â æèðîâîé òêàíè çàìåäëÿåòñÿ ïðîöåññ îáíîâëåíèÿ ëèïèäîâ, èç-çà ÷åãî îðãàíèçì ïîñòåïåííî íàêàïëèâàåò æèð. Ýòî åñòåñòâåííîå âîçðàñòíîå èçìåíåíèå îáúÿñíÿåò, ïî÷åìó ïîñëå 40 ëåò òåëî íà÷èíàåò "ðàáîòàòü" èíà÷å, ñïîñîáñòâóÿ íàáîðó âåñà.  äîëãîñðî÷íîì èññëåäîâàíèè ñïåöèàëèñòû íàáëþäàëè çà æèðîâîé òêàíüþ 54 ìóæ÷èí è æåíùèí íà ïðîòÿæåíèè â ñðåäíåì 13 ëåò. Íåçàâèñèìî îò òîãî, íàáèðàëè ó÷àñòíèêè âåñ èëè, íàîáîðîò, õóäåëè, ó âñåõ áåç èñêëþ÷åíèÿ ñêîðîñòü ëèïèäíîãî îáìåíà â æèðîâûõ êëåòêàõ çàìåòíî ñíèæàëàñü. Æèð â êëåòêàõ îáíîâëÿåòñÿ âñå ìåäëåííåå, è ýòîò ïðîöåññ ïðîèñõîäèò àâòîìàòè÷åñêè ñ òå÷åíèåì âðåìåíè. Òå, êòî íå êîìïåíñèðîâàë çàìåäëåíèå óìåíüøåíèåì êàëîðèéíîñòè ïèòàíèÿ, â ñðåäíåì íàáèðàëè îêîëî 20% îò èñõîäíîãî â ...>>

Ñëó÷àéíàÿ íîâîñòü èç Àðõèâà

Äâà ãðèáêà íà øîêîëàäå 14.09.2000

Äî 1995 ãîäà Áðàçèëèÿ áûëà âåäóùèì ýêñïîðòåðîì áîáîâ êàêàî â ìèðå. Ñ òåõ ïîð áðàçèëüñêèé óðîæàé êàêàî ñîêðàòèëñÿ ïðèìåðíî â ÷åòûðå ðàçà.

Ïðè÷èíà - ãðèáîê Crinipellis pemiciosa, íàïàâøèé íà ïëàíòàöèè. Îí âûçûâàåò íà âåòâÿõ äåðåâà êàêàî "âåäüìèíû ìåòëû" è, ÷òî åùå âàæíåå, ðàçðóøàåò ñàìè áîáû äåðåâà. Íî ó÷åíûå çàìåòèëè, ÷òî èíîãäà íà ýòîì ãðèáêå â ïîéìå Àìàçîíêè çàâîäèòñÿ äðóãîé ãðèáîê, íàçûâàåìûé Trichoderma viride.

Èññëåäîâàòåëè èç Ìèíèñòåðñòâà ñåëüñêîãî õîçÿéñòâà ÑØÀ âìåñòå ñ áðàçèëüñêèìè ó÷åíûìè ïðåäëîæèëè ôåðìåðàì îïðûñêèâàòü äåðåâüÿ ñïîðàìè òðèõîäåðìû. Óæå ïîÿâèëèñü ïðèçíàêè îçäîðîâëåíèÿ ïëàíòàöèé, íî ÿñíî, ÷òî â áëèæàéøèå íåñêîëüêî ëåò âåðíóòü óðîæàé ê íîðìå íå óäàñòñÿ, è öåíû íà øîêîëàä áóäóò ïðîäîëæàòü ðàñòè.

Äðóãèå èíòåðåñíûå íîâîñòè:

▪ Íîâàÿ ëèíçà óëè÷íîãî LED ñâåòèëüíèêà 2õ6

▪ Ïåñíè â ÷àñàõ

▪ Ïåðåêëþ÷àòåëè àóäèîñèãíàëîâ DALLAS SEMICONDUCTOR-MAXIM

▪ Â æàðó íå äî ëþáâè

▪ NASA çàïëàòèò 18000 åâðî çà äâà ìåñÿöà â ïîñòåëè

Ëåíòà íîâîñòåé íàóêè è òåõíèêè, íîâèíîê ýëåêòðîíèêè

 

Èíòåðåñíûå ìàòåðèàëû Áåñïëàòíîé òåõíè÷åñêîé áèáëèîòåêè:

▪ ðàçäåë ñàéòà Ìåòàëëîèñêàòåëè. Ïîäáîðêà ñòàòåé

▪ ñòàòüÿ Ôàðìàêîëîãèÿ. Êîíñïåêò ëåêöèé

▪ ñòàòüÿ Â êàêîì ÿçûêå íåò ñëîâ äà è íåò? Ïîäðîáíûé îòâåò

▪ ñòàòüÿ Ðóêîâîäèòåëü (äèðåêòîð, íà÷àëüíèê, çàâåäóþùèé) ó÷ðåæäåíèÿ îáðàçîâàíèÿ. Äîëæíîñòíàÿ èíñòðóêöèÿ

▪ ñòàòüÿ Ôóíêöèîíàëüíûé ãåíåðàòîð ñ ýëåêòðîííîé ïåðåñòðîéêîé ÷àñòîòû. Ýíöèêëîïåäèÿ ðàäèîýëåêòðîíèêè è ýëåêòðîòåõíèêè

▪ ñòàòüÿ Äâà óñòðîéñòâà äëÿ àâàðèéíîé çàùèòû îò ïðåâûøåíèÿ ñåòåâîãî íàïðÿæåíèÿ. Ýíöèêëîïåäèÿ ðàäèîýëåêòðîíèêè è ýëåêòðîòåõíèêè

Îñòàâüòå ñâîé êîììåíòàðèé ê ýòîé ñòàòüå:

Èìÿ:


E-mail (íå îáÿçàòåëüíî):


Êîììåíòàðèé:





Ãëàâíàÿ ñòðàíèöà | Áèáëèîòåêà | Ñòàòüè | Êàðòà ñàéòà | Îòçûâû î ñàéòå

www.diagram.com.ua

www.diagram.com.ua
2000-2026